The rate of HPV, a sexually transmitted virus that is the main cause of cervical cancer, has dropped 56% among 14-19 year-old young women since the first vaccine was introduced by Merck (MRK) in 2006. The results have been so good that the director of the Centers for Disease Control & Prevention, Thomas Frieden, wants to "protect a generation from cancer" by increasing vaccination. Merck's drug, Gardasil, generated $1.6B in sales in 2012, while one from GlaxoSmithKline (GSK), Cervarix, earned $428M.
The rate of HPV, a sexually transmitted virus that is the main cause of cervical cancer, has...
From other sites
Video at CNBC.com (Jun 16, 2016)
Video at CNBC.com (Jun 6, 2016)
Video at CNBC.com (Jun 3, 2016)
Video at CNBC.com (May 5, 2016)
Video at CNBC.com (Apr 6, 2016)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs